精选合成化合物的脏保护潜力,可以防止 gentamicin 诱导的脏毒性
Sony Amir1, Muhammad Abid1, Humaira Nadeem2
1Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
BMC pharmacology & toxicology
|September 28, 2024
概括
一种合成的化合物5-a,在老鼠中显示出显著的保护作用,防止 gentamicin 诱导的毒性. 这种化合物减少了损伤和炎症,为脏疾病提供了潜在的治疗策略.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 药用化学 医学化学
- 脏生理学 脏生理学
背景情况:
- 毒性是诸如 gentamicin 这样的药物的显著副作用,会损害功能,并与活性氧物种 (ROS) 相关.
- 根他米辛 (GM) 是一种氨基糖类抗生素,是已知的人类和动物毒性的原因.
- 反应性氧物种 (ROS) 在各种毒理条件下导致细胞损伤和器官功能障碍.
研究的目的:
- 为了研究合成化合物5-a对大鼠模型中 gentamicin 诱导的毒性的保护作用.
- 评估化合物5-a在减轻脏损伤方面的抗炎和抗氧化潜力.
- 探索化合物5-a作为一种潜在的治疗剂 gentamicin诱导的损伤.
主要方法:
- 雄性Wistar白色老鼠被分为五组:对照组, gentamicin 诱导的毒性,以及 gentamicin 用不同剂量的 5-a 化合物或甲.
- 评估包括监测老鼠体重,分析血清和脏组织以检测功能标志物和炎症指标.
- 进行了组织病理学分析,分子对接,电解质平衡评估和行为研究.
主要成果:
- 化合物5-a显著保护 gentamicin 诱导的损伤,减少炎症标志物和改善抗氧化防御.
- 较高剂量的5-a化合物显示出对损伤的更明显的保护作用.
- 该化合物的抗炎和抗氧化特性是其脏保护作用的关键.
结论:
- 化合物5-a在减轻 gentamicin 诱导的毒性方面表现出显著的治疗作用.
- 这些发现表明,5-a化合物是治疗胺素诱导的损伤的有希望的候选物.
- 化合物5-a可能有潜力在未来治疗其他脏疾病.
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
8
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
8
01:15Drug Elimination by Renal Route: Tubular Secretion
2.2K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
395
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
395
01:28Renal Drug Excretion: Tubular Secretion
148
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
148
01:26Heart Failure Drugs: Inotropic Agents
535
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
535
01:22Drug Elimination by Renal Route: Tubular Reabsorption
3.2K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.2K